The company in question is, Sanofi (NYSE:SNY) currently with a stock price of 44.31 (-0.31% today). The market cap for Sanofi is 113561.22, and is in the sector Healthcare, and Drug Manufacturers – Major industry. The target price for Sanofi is 47. Currently Sanofi is trading with a P/E of 24.63, and a forward P/E of 13.86. Average volume for Sanofi is 1470.49 and so far today it is 1527300.
Performance in the last year for Sanofi has been 4.49%. For EPS growth, Sanofi has seen a growth of 1.40%, and is looking to grow in the next year to 5.41%. More long term stats show that EPS growth has been -4.60% over the last five years and could be 7.00% for the next five years. Sanofi has seen sales growth quarter over quarter at 3.30%, with EPS growth quarter over quarter at 12.90%. The 20-day simple moving average is -1.65%, with the 200-day simple moving average coming to 8.37%.
Since the IPO date for Sanofi on the 07/01/2002, Sanofi has seen performance year to date to be 9.57%. With Sanofi trading at 44.31, the dividend yield is 3.57%, and the EPS is 1.8.
So could Sanofi, be undervalued? Well as said before P/E is 24.63. The PEG is 3.52, P/S is 3.08 and the P/B is at 1.87. The P/cash is *TBA, with P/free cash flow at *TBA.
Sanofi ability to deal with debt shows that the current ratio is 1.6, and the quick ratio is 1.2. This is with long term debt/equity at 0.29, and total debt/equity at 0.32.
In terms of margins, Sanofi has a gross margin of 69.20%, an operating margin of *TBA and a profit margin of *TBA.Payout ratio for Sanofi is *TBA. Return on assets come to *TBA with return on investment coming to 6.20%.
Insider ownership for Sanofi, is at 16.40% and institutional ownership comes to 10.70%. Outstanding shares are at 2562.88. While shares float is 2354.16. The float short is currently 0.21%, and short ratio is 3.4.
Graphs: Sanofi NYSE: SNY | Thursday April 20, 2017
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.